224 related articles for article (PubMed ID: 16939409)
1. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase.
Karakelides H; Geller JL; Schroeter AL; Chen H; Behn PS; Adams JS; Hewison M; Wermers RA
J Bone Miner Res; 2006 Sep; 21(9):1496-9. PubMed ID: 16939409
[TBL] [Abstract][Full Text] [Related]
2. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis.
Farooque A; Moss C; Zehnder D; Hewison M; Shaw NJ
Br J Dermatol; 2009 Feb; 160(2):423-5. PubMed ID: 18811689
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages.
Hewison M; Kantorovich V; Liker HR; Van Herle AJ; Cohan P; Zehnder D; Adams JS
J Bone Miner Res; 2003 Mar; 18(3):579-82. PubMed ID: 12619944
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas.
Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M
Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427
[TBL] [Abstract][Full Text] [Related]
5. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.
Zehnder D; Bland R; Williams MC; McNinch RW; Howie AJ; Stewart PM; Hewison M
J Clin Endocrinol Metab; 2001 Feb; 86(2):888-94. PubMed ID: 11158062
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.
Evans KN; Taylor H; Zehnder D; Kilby MD; Bulmer JN; Shah F; Adams JS; Hewison M
Am J Pathol; 2004 Sep; 165(3):807-13. PubMed ID: 15331405
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
9. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease.
Bosch X
JAMA; 1998 Feb; 279(7):532-4. PubMed ID: 9480364
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia associated with mineral oil-induced sclerosing paraffinomas.
Moraitis AG; Hewison M; Collins M; Anaya C; Holick MF
Endocr Pract; 2013; 19(2):e50-6. PubMed ID: 23337133
[TBL] [Abstract][Full Text] [Related]
12. A case of severe 1,25-dihydroxyvitamin D-mediated hypercalcemia due to a granulomatous disorder.
Zhang JT; Chan C; Kwun SY; Benson KA
J Clin Endocrinol Metab; 2012 Aug; 97(8):2579-83. PubMed ID: 22639294
[TBL] [Abstract][Full Text] [Related]
13. CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin.
Vanhooke JL; Prahl JM; Kimmel-Jehan C; Mendelsohn M; Danielson EW; Healy KD; DeLuca HF
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):75-80. PubMed ID: 16371465
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D-mediated hypercalcemia in multicentric Castleman's disease.
Tanaka KI; Kanazawa I; Miyake H; Yano S; Amano C; Ishikawa N; Maruyama R; Sugimoto T
J Bone Miner Metab; 2017 Jan; 35(1):122-125. PubMed ID: 26597827
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma cells express 25(OH)D-1α-hydroxylase and are able to convert 25(OH)D to 1α,25(OH)₂D, leading to the 25(OH)D-induced growth inhibition.
Chiang KC; Yen CL; Yeh CN; Hsu JT; Chen LW; Kuo SF; Wang SY; Sun CC; Kittaka A; Chen TC; Yeh TS; Hsu SY; Juang HH
J Steroid Biochem Mol Biol; 2015 Nov; 154():47-52. PubMed ID: 26170242
[TBL] [Abstract][Full Text] [Related]
16. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3).
Jones G
Semin Dial; 2007; 20(4):316-24. PubMed ID: 17635821
[TBL] [Abstract][Full Text] [Related]
17. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system.
Viganò P; Lattuada D; Mangioni S; Ermellino L; Vignali M; Caporizzo E; Panina-Bordignon P; Besozzi M; Di Blasio AM
J Mol Endocrinol; 2006 Jun; 36(3):415-24. PubMed ID: 16720713
[TBL] [Abstract][Full Text] [Related]
18. Enhancing 1 alpha-hydroxylase activity with the 25-hydroxyvitamin D-1 alpha-hydroxylase gene in cultured human keratinocytes and mouse skin.
Flanagan JN; Whitlatch LW; Chen TC; Zhu XH; Holick MT; Kong XF; Holick MF
J Invest Dermatol; 2001 Jun; 116(6):910-4. PubMed ID: 11407980
[TBL] [Abstract][Full Text] [Related]
19. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.
Segersten U; Correa P; Hewison M; Hellman P; Dralle H; Carling T; Akerström G; Westin G
J Clin Endocrinol Metab; 2002 Jun; 87(6):2967-72. PubMed ID: 12050281
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma.
Lee JM; Pou K; Sadow PM; Chen H; Hu B; Hewison M; Adams JS; Sugarbaker DJ; Fisher ND
Endocr Pract; 2008 Nov; 14(8):1011-6. PubMed ID: 19095601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
